These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 26297795)
1. Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity. Masuda Y; Nawa D; Nakayama Y; Konishi M; Nanba H J Leukoc Biol; 2015 Dec; 98(6):1015-25. PubMed ID: 26297795 [TBL] [Abstract][Full Text] [Related]
2. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice. Masuda Y; Inoue H; Ohta H; Miyake A; Konishi M; Nanba H Int J Cancer; 2013 Jul; 133(1):108-19. PubMed ID: 23280601 [TBL] [Abstract][Full Text] [Related]
3. Maturation of dendritic cells by maitake α-glucan enhances anti-cancer effect of dendritic cell vaccination. Masuda Y; Nakayama Y; Mukae T; Tanaka A; Naito K; Konishi M Int Immunopharmacol; 2019 Feb; 67():408-416. PubMed ID: 30586664 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel maitake (Grifola frondosa) protein that activates natural killer and dendritic cells and enhances antitumor immunity in mice. Tsao YW; Kuan YC; Wang JL; Sheu F J Agric Food Chem; 2013 Oct; 61(41):9828-38. PubMed ID: 24020458 [TBL] [Abstract][Full Text] [Related]
5. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice. Kodama N; Murata Y; Asakawa A; Inui A; Hayashi M; Sakai N; Nanba H Nutrition; 2005 May; 21(5):624-9. PubMed ID: 15850970 [TBL] [Abstract][Full Text] [Related]
6. Administration of a polysaccharide from Grifola frondosa stimulates immune function of normal mice. Kodama N; Murata Y; Nanba H J Med Food; 2004; 7(2):141-5. PubMed ID: 15298759 [TBL] [Abstract][Full Text] [Related]
7. Species-dependent role of type I IFNs and IL-12 in the CTL response induced by humanized CpG complexed with β-glucan. Kobiyama K; Temizoz B; Kanuma T; Ozasa K; Momota M; Yamamoto T; Aoshi T; Kuroda E; Ishii KJ Eur J Immunol; 2016 May; 46(5):1142-51. PubMed ID: 26786557 [TBL] [Abstract][Full Text] [Related]
8. Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients. Kodama N; Komuta K; Nanba H J Med Food; 2003; 6(4):371-7. PubMed ID: 14977447 [TBL] [Abstract][Full Text] [Related]
9. Maitake beta-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice. Masuda Y; Inoue M; Miyata A; Mizuno S; Nanba H Int Immunopharmacol; 2009 May; 9(5):620-6. PubMed ID: 19249389 [TBL] [Abstract][Full Text] [Related]
10. Soluble β-glucan from Grifola frondosa induces proliferation and Dectin-1/Syk signaling in resident macrophages via the GM-CSF autocrine pathway. Masuda Y; Togo T; Mizuno S; Konishi M; Nanba H J Leukoc Biol; 2012 Apr; 91(4):547-56. PubMed ID: 22028332 [TBL] [Abstract][Full Text] [Related]
11. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity. Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787 [TBL] [Abstract][Full Text] [Related]
12. A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer. Masuda Y; Ito K; Konishi M; Nanba H Cancer Immunol Immunother; 2010 Oct; 59(10):1531-41. PubMed ID: 20563803 [TBL] [Abstract][Full Text] [Related]
13. Cheng Y; Lemke-Miltner CD; Wongpattaraworakul W; Wang Z; Chan CHF; Salem AK; Weiner GJ; Simons AL J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33060147 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of orally administered maitake α-glucan by stimulating antitumor immune response in murine tumor. Masuda Y; Nakayama Y; Tanaka A; Naito K; Konishi M PLoS One; 2017; 12(3):e0173621. PubMed ID: 28278221 [TBL] [Abstract][Full Text] [Related]
15. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents. Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033 [TBL] [Abstract][Full Text] [Related]
16. Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine. Karan D; Krieg AM; Lubaroff DM Int J Cancer; 2007 Oct; 121(7):1520-8. PubMed ID: 17565748 [TBL] [Abstract][Full Text] [Related]
17. The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphoma. Pradhan P; Qin H; Leleux JA; Gwak D; Sakamaki I; Kwak LW; Roy K Biomaterials; 2014 Jul; 35(21):5491-504. PubMed ID: 24720881 [TBL] [Abstract][Full Text] [Related]
18. Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): preparation and immunological analysis of vaccine efficacy. Masuko K; Wakita D; Togashi Y; Kita T; Kitamura H; Nishimura T Immunol Lett; 2015 Jan; 163(1):102-12. PubMed ID: 25479286 [TBL] [Abstract][Full Text] [Related]
19. CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumor. Yuan S; Qiao T; Chen W Cancer Biother Radiopharm; 2011 Apr; 26(2):203-8. PubMed ID: 21539452 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of cytotoxicity of NK cells by D-Fraction, a polysaccharide from Grifola frondosa. Kodama N; Asakawa A; Inui A; Masuda Y; Nanba H Oncol Rep; 2005 Mar; 13(3):497-502. PubMed ID: 15706424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]